Arterial Abnormalities in the Offspring of Patients with Premature Myocardial Infarction

University of Naples Federico II, Napoli, Campania, Italy
New England Journal of Medicine (Impact Factor: 55.87). 10/2000; 343(12):840-6. DOI: 10.1056/NEJM200009213431203
Source: PubMed


Findings from epidemiologic and autopsy studies suggest that the offspring of patients with premature coronary disease may be at increased risk for atherosclerosis. We undertook a study to determine whether changes in brachial-artery reactivity and thickness of the carotid intima and media, two markers of early atherosclerosis, are present in adolescents and young adults with a parental history of premature myocardial infarction.
We enrolled 40 healthy young people whose parents had had premature myocardial infarction (48 percent male; mean [+/-SD] age, 19.0+/-5.2 years) and 40 control subjects who were matched with the first group according to age and sex. All the subjects underwent high-resolution B-mode ultrasound examinations for the measurement of the brachial-artery vasodilatory response after arterial occlusion (i.e., reactive hyperemia) and the intima-media thickness of the distal common carotid arteries. Lipid profiles, blood pressure while at rest, body-mass index, and smoking status were also determined.
As compared with the control subjects, the offspring of patients with premature myocardial infarction had lower flow-mediated reactivity of the brachial arteries (5.7+/-5.0 percent, vs. 10.2+/-6.6 percent in the control subjects; P=0.001) and greater mean intima-media thickness of the common carotid artery (0.49+/-0.08 mm, vs. 0.44+/-0.07 mm in the control subjects, P=0.004). In the subjects with a parental history of premature myocardial infarction, an inverse association was found between brachial-artery reactivity and carotid intima-media thickness (r=-0.46, P=0.003). In a conditional logistic-regression analysis, both brachial-artery reactivity and carotid intima-media thickness were significantly and independently correlated with a parental history of premature myocardial infarction.
Structural and functional changes are present at an early age in the arteries of persons with a parental history of premature myocardial infarction.

Download full-text


Available from: Giovanni Gaeta, Dec 13, 2013
  • Source
    • "Regarding the presence of atherosclerosis (a prognostically wellvalidated non-invasive surrogate endpoint to assess cardiovascular risk), the eFH low-risk group had significantly less atherosclerosis compared to the eFH moderate-and high-risk groups. Although other studies already demonstrated significantly more atherosclerosis in patients with a FH of CVD[37,38]. Our study shows, for the first time, that this is in large part due to significantly less atherosclerosis in a ''low-risk'' group that can be readily identified by eFH (but not by cFH), separating it from an intermediate group (which would conventionally be classified as having a negative FH). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whereas the importance of family history (FH) is widely recognized in cardiovascular risk assessment, its full potential could be underutilized, when applied with its current simple guidelines-based definition (cFH): presence of premature cardiovascular disease (CVD) in a first-degree relative. We tested the added value of a new, extended family history definition (eFH), also taking into account later onset of disease, second-degree relatives and number of affected relatives, on profiling cardiovascular risk and atherosclerotic burden in the general population. longitudinal population study. random, representative population sample from Erpe-Mere and Nieuwerkerken (Belgium, primary care). 2524 male/female volunteers, aged 35-55 years, free from overt CVD. Subjects were extensively phenotyped including presence of atherosclerosis (ultrasound) and a newly developed FH questionnaire (4 generations). Compared to cFH, eFH was superior in predicting an adverse risk profile (glycemic state, elevated blood pressure, lipid abnormalities, presence of metabolic syndrome components) and presence of atherosclerosis (all age & sex-adjusted p<0.05). Unlike cFH, eFH remained a significant predictor of subclinical atherosclerosis after adjusting for confounders. Most relations with eFH were not graded but showed clear informational breakpoints, with absence of CVD (including late onset) in any first-degree relative being a negative predictor of atherosclerosis, and a particularly interesting phenotype for further study. A novel, extended FH definition is superior to the conventional definition in profiling cardiovascular risk and atherosclerotic burden in the general population. There remain clear opportunities to refine and increase the performance and informational content of this simple, readily-available inexpensive tool.
    Full-text · Article · May 2013 · PLoS ONE
  • Source
    • "Assessment of flow-mediated dilatation of the brachial artery safely and non-invasively provides a measure of the systemic endothelial function. The brachial artery response to increased shear stress has been shown to correlate significantly with invasive testing of brachial (Irace et al., 2001) and coronary endothelial function (Andersson et al., 1995), as well as with the extent and severity of coronary atherosclerosis (Neunteufl et al., 1997), and carotid artery intima-media thickness (Gaeta et al., 2000). "

    Full-text · Chapter · Nov 2011
  • Source
    • "Genetic factors have long been known to modulate risk of atherosclerosis and CVD [32, 33]. In studies enriched with diabetic individuals or those with CVD, the genetic contribution to variation in carotid artery IMT ranges from 42%–92% [14, 34, 35]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genes of the 5-lipoxygenase pathway are compelling candidates for atherosclerosis. We hypothesize that polymorphisms in ALOX12, ALOX15, ALOX5, and ALOX5AP genes are associated with subclinical atherosclerosis in multiple vascular beds. Families with two or more siblings with type 2 diabetes and their nondiabetic siblings were studied as part of the Diabetes Heart Study (DHS). European American diabetic (n = 828) and nondiabetic (n = 170) siblings were genotyped for SNPs in the ALOX12, ALOX15, ALOX5, and ALOX5AP genes. Subclinical measures of atherosclerosis (IMT, coronary (CorCP), carotid (CarCP) and aortic (AorCP) calcified plaque) were obtained. Associations were observed between ALOX12 with CorCP, ALOX5 with CorCP, AorCP, and IMT, and ALOX5AP with CorCP and CarCP, independent of known epidemiologic risk factors. Further, lipoxygenase pathway SNPs that were associated with measures of atherosclerosis were associated with markers of inflammation (CRP, ICAM-1) and calcification (MGP). Polymorphisms within ALOX12, ALOX5, and ALOX5AP are genetically associated with subclinical atherosclerosis and with biomarkers of disease in families with type 2 diabetes. These results suggest that variants in lipoxygenase pathway genes may have pleiotropic effects on multiple components that determine risk of cardiovascular disease.
    Full-text · Article · May 2010 · Mediators of Inflammation
Show more